Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$86.26 - $119.0 $159,494 - $220,031
-1,849 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$86.05 - $119.72 $159,106 - $221,362
1,849 New
1,849 $210,000
Q1 2021

May 07, 2021

SELL
$91.47 - $124.36 $214,863 - $292,121
-2,349 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$66.66 - $111.74 $156,584 - $262,477
2,349 New
2,349 $234,000
Q3 2020

Nov 12, 2020

SELL
$45.89 - $72.67 $107,795 - $170,701
-2,349 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$26.36 - $49.86 $61,919 - $117,121
2,349 New
2,349 $117,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Boston Financial Mangement LLC Portfolio

Follow Boston Financial Mangement LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.